$2.45T
Total marketcap
$64.5B
Total volume
BTC 50.75%     ETH 15.10%
Dominance

Ceapro CRPOF Stock

0.18 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
14.2M USD
LOW - HIGH [24H]
0.18 - 0.18 USD
VOLUME [24H]
500 USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.02 USD

Ceapro Price Chart

Ceapro CRPOF Financial and Trading Overview

Ceapro stock price 0.18 USD
Previous Close 0.37 USD
Open 0.34 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0.34 - 0.34 USD
52 Week Range 0.32 - 0.61 USD
Volume 14K USD
Avg. Volume 10.63K USD
Market Cap 26.93M USD
Beta (5Y Monthly) 1.527657
PE Ratio (TTM) 17.205
EPS (TTM) -0.02 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

CRPOF Valuation Measures

Enterprise Value 18.56M USD
Trailing P/E 17.205
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 1.6659821
Price/Book (mrq) 0.8413203
Enterprise Value/Revenue 1.148
Enterprise Value/EBITDA 5.929

Trading Information

Ceapro Stock Price History

Beta (5Y Monthly) 1.527657
52-Week Change -21.46%
S&P500 52-Week Change 20.43%
52 Week High 0.61 USD
52 Week Low 0.32 USD
50-Day Moving Average 0.4 USD
200-Day Moving Average 0.49 USD

CRPOF Share Statistics

Avg. Volume (3 month) 10.63K USD
Avg. Daily Volume (10-Days) 8.93K USD
Shares Outstanding 78.25M
Float 75.16M
Short Ratio N/A
% Held by Insiders 3.91%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 13.61%
Operating Margin (ttm) 14.95%
Gross Margin 55.12%
EBITDA Margin 19.36%

Management Effectiveness

Return on Assets (ttm) 4.36%
Return on Equity (ttm) 7.18%

Income Statement

Revenue (ttm) 16.16M USD
Revenue Per Share (ttm) 0.21 USD
Quarterly Revenue Growth (yoy) -43.39%
Gross Profit (ttm) N/A
EBITDA 3.13M USD
Net Income Avi to Common (ttm) 2.2M USD
Diluted EPS (ttm) 0.02
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 12.56M USD
Total Cash Per Share (mrq) 0.16 USD
Total Debt (mrq) 2.53M USD
Total Debt/Equity (mrq) 7.91 USD
Current Ratio (mrq) 13.625
Book Value Per Share (mrq) 0.409

Cash Flow Statement

Operating Cash Flow (ttm) 4.22M USD
Levered Free Cash Flow (ttm) 1.38M USD

Profile of Ceapro

Country United States
State AB
City Edmonton
Address 7824 – 51 Avenue NW
ZIP T6E 6W2
Phone 780-421-4555
Website https://www.ceapro.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees N/A

Ceapro Inc., a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries. It also offers natural active ingredients, including oat powder, oat oil, oat peptides, and lupin peptides to the personal care, cosmetic, medical, and animal health industries; anti-aging skincare products to the cosmeceutical industries; and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner. The company was incorporated in 1997 and is headquartered in Edmonton, Canada.

Q&A For Ceapro Stock

What is a current CRPOF stock price?

Ceapro CRPOF stock price today per share is 0.18 USD.

How to purchase Ceapro stock?

You can buy CRPOF shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Ceapro?

The stock symbol or ticker of Ceapro is CRPOF.

Which industry does the Ceapro company belong to?

The Ceapro industry is Biotechnology.

How many shares does Ceapro have in circulation?

The max supply of Ceapro shares is 78.3M.

What is Ceapro Price to Earnings Ratio (PE Ratio)?

Ceapro PE Ratio is now.

What was Ceapro earnings per share over the trailing 12 months (TTM)?

Ceapro EPS is -0.02 USD over the trailing 12 months.

Which sector does the Ceapro company belong to?

The Ceapro sector is Healthcare.